CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.3333
+0.01
(+4.06%)
After-Hours: 19:06
CollPlant Biotechnologies Net Income (Quarterly) : -3.097M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.097M |
| December 31, 2025 | -3.207M |
| September 30, 2025 | -3.483M |
| June 30, 2025 | -3.347M |
| March 31, 2025 | -1.452M |
| December 31, 2024 | -3.878M |
| September 30, 2024 | -4.326M |
| June 30, 2024 | -4.21M |
| March 31, 2024 | -4.195M |
| December 31, 2023 | -4.689M |
| September 30, 2023 | -4.377M |
| June 30, 2023 | 5.762M |
| March 31, 2023 | -3.715M |
| December 31, 2022 | -4.401M |
| September 30, 2022 | -4.379M |
| June 30, 2022 | -4.285M |
| March 31, 2022 | -3.86M |
| December 31, 2021 | -3.772M |
| September 30, 2021 | -3.077M |
| June 30, 2021 | -3.038M |
| March 31, 2021 | 10.12M |
| December 31, 2020 | -2.905M |
| September 30, 2020 | 0.703M |
| June 30, 2020 | -1.971M |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | -3.177M |
| June 30, 2019 | -1.248M |
| March 31, 2019 | -2.038M |
| December 31, 2018 | 1.02M |
| September 30, 2018 | -1.334M |
| June 30, 2018 | -1.559M |
| March 31, 2018 | -2.092M |
| December 31, 2017 | -1.684M |
| September 30, 2017 | -1.104M |
| June 30, 2017 | -1.629M |
| March 31, 2017 | -1.393M |
| December 31, 2016 | -1.839M |
| September 30, 2016 | -1.795M |
| June 30, 2016 | -1.674M |
| March 31, 2016 | -1.952M |
| December 31, 2015 | -0.9953M |
| September 30, 2015 | -1.169M |
| June 30, 2015 | -0.9971M |
| March 31, 2015 | -0.8783M |
| December 31, 2014 | -0.9254M |
| September 30, 2014 | -0.7625M |
| June 30, 2014 | -0.8661M |
| March 31, 2014 | -1.086M |
| December 31, 2013 | -1.331M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -14.84M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.073M |
| Total Expenses (Quarterly) | 3.17M |
| EPS Diluted (Quarterly) | -0.2253 |
| Enterprise Value | 2.974M |
| Gross Profit Margin (Quarterly) | -620.5% |
| Profit Margin (Quarterly) | -4.24K% |
| Earnings Yield | -322.3% |
| Normalized Earnings Yield | -322.26 |